Education
About Us
Working with TipRanks
Follow Us
Pro Medicus Limited (AU:PME)
ASX:PME
PME Stock Chart & Stats
AU$233.69
AU$10.00(3.86%)
At close: 4:00 PM EST
AU$233.69
AU$10.00(3.86%)
Day’s Range― - ―
52-Week RangeAU$161.64 - AU$336.00
Previous CloseN/A
Volume110.53K
Average Volume (3M)179.98K
Market Cap
AU$24.50B
Enterprise ValueAU$29.63B
Total Cash (Recent Filing)AU$209.19M
Total Debt (Recent Filing)AU$2.25M
Price to Earnings (P/E)212.6
Beta1.61
Next Earnings
Feb 17, 2026EPS Estimate
0.68Next Dividend Ex-DateN/A
Dividend Yield0.23%
Share Statistics
EPS (TTM)0.61
Shares Outstanding104,510,840
10 Day Avg. Volume188,916
30 Day Avg. Volume179,984
Financial Highlights & Ratios
PEG Ratio6.59
Price to Book (P/B)115.91
Price to Sales (P/S)139.89
P/FCF Ratio286.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$332.01Price Target Upside42.07% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)1.45
Revenue Forecast (FY)AU$284.26M
Bulls Say, Bears Say
Bulls Say
Market AcceptanceOver 55% of surveyed US hospital executives are likely to deploy Pro Medicus's Visage 7 software, highlighting strong market acceptance and growth potential.
Product InnovationThe Visage 7 software from Pro Medicus creates significant value for customers, making it 60-70% faster than legacy solutions and boosting customer volumes significantly.
Bears Say
Market PenetrationPME's share of the US market remains low at 7%, which highlights the opportunity ahead, notwithstanding upside prospects from the core TAM, adjacencies and potential new markets.
Pro Medicus Limited News
PME FAQ
What was Pro Medicus Limited’s price range in the past 12 months?
Pro Medicus Limited lowest share price was AU$161.64 and its highest was AU$336.00 in the past 12 months.
What is Pro Medicus Limited’s market cap?
Pro Medicus Limited’s market cap is AU$24.50B.
When is Pro Medicus Limited’s upcoming earnings report date?
Pro Medicus Limited’s upcoming earnings report date is Feb 17, 2026 which is in 62 days.
How were Pro Medicus Limited’s earnings last quarter?
Pro Medicus Limited released its earnings results on Aug 13, 2025. The company reported AU$0.606 earnings per share for the quarter, beating the consensus estimate of AU$0.581 by AU$0.025.
Is Pro Medicus Limited overvalued?
According to Wall Street analysts Pro Medicus Limited’s price is currently Undervalued.
Does Pro Medicus Limited pay dividends?
Pro Medicus Limited pays a Semiannually dividend of AU$0.3 which represents an annual dividend yield of 0.23%. See more information on Pro Medicus Limited dividends here
What is Pro Medicus Limited’s EPS estimate?
Pro Medicus Limited’s EPS estimate is 0.68.
How many shares outstanding does Pro Medicus Limited have?
Pro Medicus Limited has 104,510,840 shares outstanding.
What happened to Pro Medicus Limited’s price movement after its last earnings report?
Pro Medicus Limited reported an EPS of AU$0.606 in its last earnings report, beating expectations of AU$0.581. Following the earnings report the stock price went up 6.239%.
Which hedge fund is a major shareholder of Pro Medicus Limited?
Currently, no hedge funds are holding shares in AU:PME
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Pro Medicus Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$332.01 (42.07% Upside)
AU$332.01 (42.07% Upside)
Blogger Sentiment
Bullish
AU:PME Sentiment 80%
Sector Average 68%
Sector Average 68%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-2.09%
12-Months-Change
Fundamentals
Return on Equity
50.70%
Trailing 12-Months
Asset Growth
29.11%
Trailing 12-Months
Company Description
Pro Medicus Limited
Pro Medicus Limited (PME) is a leading healthcare technology company based in Australia, primarily focused on providing innovative software solutions for the medical imaging sector. The company specializes in developing advanced radiology information systems and picture archiving and communication systems (PACS) that enhance the efficiency of medical imaging workflows. PME's core products include its Visage Imaging platform, which utilizes cutting-edge technology for fast and reliable medical image management, analysis, and sharing, catering to hospitals, radiology practices, and imaging centers worldwide.
PME Company Deck
PME Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance with record revenue and profit growth, significant contract wins, and advancements in cloud and AI technology. However, challenges remain in expanding market penetration outside North America and navigating a competitive landscape.View all AU:PME earnings summariesPME Stock 12 Month Forecast
Average Price Target
AU$332.01
▲(42.07% Upside)
Technical Analysis
Mach7 Technologies
―
Resonance Health Ltd
―
MedAdvisor Limited
―
Alcidion Group Limited
―
PainChek Ltd
―
Options Prices
Currently, No data available
---